Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cytokinetics

58.60
-0.7500-1.26%
Volume:56.54K
Turnover:3.32M
Market Cap:7.01B
PE:-11.45
High:59.47
Open:59.42
Low:58.14
Close:59.35
52wk High:63.86
52wk Low:29.31
Shares:119.66M
Float Shares:119.09M
Volume Ratio:0.26
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.1182
EPS(LYR):-5.2646
ROE:-572.15%
ROA:-24.87%
PB:-19.02
PE(LYR):-11.13

Loading ...

Cytokinetics’ Aficamten Faces Competitive and Regulatory Challenges: Hold Rating Maintained

TIPRANKS
·
3 hours ago

Cytokinetics Faces Class Action Lawsuit Over Alleged Securities Fraud

Reuters
·
18 hours ago

Verisign, HEICO, Transdigm, Albertsons, Cytokinetics: Insider Moves Unveiled!

TIPRANKS
·
Oct 18

Cytokinetics Grants New Stock Options and RSUs to Recent Hires

Reuters
·
Oct 18

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire
·
Oct 18

Cytokinetics CEO Cashes Out: A Major Stock Sale Unveiled!

TIPRANKS
·
Oct 17

Cytokinetics CEO Robert I. Blum Reports Sale of Common Shares

Reuters
·
Oct 17

Have Insiders Sold Cytokinetics Shares Recently?

Simply Wall St.
·
Oct 09

Top Executive Sells Thousands in Cytokinetics Stock!

TIPRANKS
·
Oct 08

Cytokinetics EVP R&D Fady Ibraham Malik Reports Disposal of Common Shares

Reuters
·
Oct 08

Cytokinetics Director Makes a Significant Stock Sale!

TIPRANKS
·
Oct 07

Cytokinetics Director Edward M. Kaye, MD Reports Disposal of Common Shares

Reuters
·
Oct 07

Cytokinetics Is Maintained at Overweight by Barclays

Dow Jones
·
Oct 06

Cytokinetics price target raised to $82 from $71 at Barclays

TIPRANKS
·
Oct 06

Cytokinetics (CYTK) Is Up 13.0% After Positive Aficamten Data and Regulatory Scrutiny - Has The Bull Case Changed?

Simply Wall St.
·
Oct 05

Cytokinetics Is Maintained at Neutral by B of A Securities

Dow Jones
·
Oct 03

Cytokinetics price target raised to $56 from $52 at BofA

TIPRANKS
·
Oct 02

Cytokinetics CEO Makes a Bold Move with Stock Sale!

TIPRANKS
·
Oct 02

Director Makes a Major Move with Cytokinetics Stock Sale!

TIPRANKS
·
Oct 01

Cytokinetics Director Dr. Edward M. Kaye Reports Disposal of Common Shares

Reuters
·
Oct 01